Neuroscience 311 (2015) 1–8
GLUCOCORTICOID ENHANCEMENT OF DORSOLATERAL STRIATUM-DEPENDENT HABIT MEMORY REQUIRES CONCURRENT NORADRENERGIC ACTIVITY Key words: corticosterone, propranolol, stress, memory, striatum, habit.
J. GOODMAN, K.-C. LEONG AND M. G. PACKARD * Department of Psychology and Institute for Neuroscience, Texas A&M University, United States
INTRODUCTION Abstract—Previous findings indicate that post-training administration of glucocorticoid stress hormones can interact with the noradrenergic system to enhance consolidation of hippocampus- or amygdala-dependent cognitive/emotional memory. The present experiments were designed to extend these findings by examining the potential interaction of glucocorticoid and noradrenergic mechanisms in enhancement of dorsolateral striatum (DLS)-dependent habit memory. In experiment 1, different groups of adult male Long–Evans rats received training in two DLS-dependent memory tasks. In a cued water maze task, rats were released from various start points and were reinforced to approach a visibly cued escape platform. In a response-learning version of the water plus-maze task, animals were released from opposite starting positions and were reinforced to make a consistent egocentric body-turn to reach a hidden escape platform. Immediately post-training, rats received peripheral injections of the glucocorticoid corticosterone (1 or 3 mg/kg) or vehicle solution. In both tasks, corticosterone (3 mg/kg) enhanced DLS-dependent habit memory. In experiment 2, a separate group of animals received training in the response learning version of the water plus-maze task and were given peripheral post-training injections of corticosterone (3 mg/kg), the b-adrenoreceptor antagonist propranolol (3 mg/kg), corticosterone and propranolol concurrently, or control vehicle solution. Corticosterone injections again enhanced DLS-dependent memory, and this effect was blocked by concurrent administration of propranolol. Propranolol administration by itself (3 mg/kg) did not influence DLS-dependent memory. Taken together, the findings indicate an interaction between glucocorticoid and noradrenergic mechanisms in DLS-dependent habit memory. Propranolol administration may be useful in treating stress-related human psychopathologies associated with a dysfunctional DLS-dependent habit memory system. Ó 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
Stress influences a wide range of learning and memory processes. Neurobehavioral studies employing both lower animals and humans indicate that stress/anxiety can either enhance or impair memory and that the direction of these effects depends in part on the type of memory being investigated (for reviews, see Packard, 2009b; Packard and Goodman, 2012, 2013; Schwabe, 2013). For instance, several studies indicate that stress/ anxiety impairs cognitive/spatial memory mediated by the hippocampus (Luine et al., 1994; Diamond et al., 1996; de Quervain et al., 1998; Kim et al., 2001; Conrad et al., 2004; Wingard and Packard, 2008; Packard and Gabriele, 2009). In contrast, stress or anxiety can enhance stimulus-response habit memory mediated by the dorsolateral striatum (DLS) in both rodents (Packard and Wingard, 2004; Elliot and Packard, 2008; Wingard and Packard, 2008; Schwabe et al., 2008; Hawley et al., 2011; Leong et al., 2012, 2015; Leong and Packard, 2014) and humans (Schwabe et al., 2007, 2008; Schwabe and Wolf, 2009, 2010; Schwabe et al., 2010a, b, 2013; Guenzel et al., 2014). Although the precise mechanisms underlying the mnemonic effects of emotional arousal have yet to be fully characterized, extensive evidence indicates a critical role for stress hormones, including catecholamines (e.g. noradrenaline) and glucocorticoids (corticosterone in rodents; cortisol in humans). Stress hormones released during an emotionally arousing experience may partially modulate memory by activating noradrenergic, glucocorticoid, or mineralocorticoid receptors in several brain areas related to learning and memory (McGaugh, 2004; Roozendaal et al., 2009). Consistent with this hypothesis, the effects of emotional arousal on hippocampus- and DLS-dependent memory can be mimicked following administration of drugs that boost stress hormone activity (Luine et al., 1993; de Quervain et al., 1998; Packard and Wingard, 2004; Medina et al., 2007; Wingard and Packard, 2008; Quirarte et al., 2009; Guenzel et al., 2014). In addition, the mnemonic effects of emotional arousal may be prevented following pharmacological blockade of noradrenergic, glucocorticoid, or mineralocorticoid receptors (Maroun and Akirav, 2008; Schwabe et al., 2009; Schwabe et al., 2010a, 2011b).
*Corresponding author. Address: Department of Psychology, Texas A&M University, College Station, TX 77843, United States. Tel: +1979-845-9504; fax: +1-979-845-4727. E-mail address:
[email protected] (M. G. Packard). Abbreviations: DLS, dorsolateral striatum; DMS, dorsomedial striatum; ITI, intertrial interval; LSD, Least Significant Difference. http://dx.doi.org/10.1016/j.neuroscience.2015.10.014 0306-4522/Ó 2015 IBRO. Published by Elsevier Ltd. All rights reserved. 1
2
J. Goodman et al. / Neuroscience 311 (2015) 1–8
Interestingly, adrenergic and glucocorticoid mechanisms can also interact to influence learning and memory processes. Several studies indicate that the memory-enhancing and impairing effects of glucocorticoid receptor stimulation may be prevented following concurrent administration of adrenoreceptor antagonists such as propranolol, suggesting that the mnemonic effects of glucocorticoids depend on concurrent noradrenergic activity (Quirarte et al., 1997; Roozendaal et al., 2004a,b, 2006b; de Quervain et al., 2007). Studies examining the interaction between adrenergic and glucocorticoid mechanisms have implemented learning and memory tasks that predominantly depend on cognitive and emotional memory processing mediated by the hippocampus, medial prefrontal cortex, and the amygdala (e.g. Quirarte et al., 1997; Roozendaal et al., 2004a, 2006a; de Quervain et al., 2007). There is evidence that stress hormone activity can also enhance stimulus-response/habit memory mediated by the DLS. However, whereas many of these studies have employed drugs targeting the noradrenergic system, relatively few studies have examined whether glucocorticoid administration might similarly facilitate learning in tasks that require DLS-dependent memory processes (Medina et al., 2007; Quirarte et al., 2009; Guenzel et al., 2014). In addition, whether the influence of glucocorticoid administration on learning in a DLSdependent memory task depends on concurrent noradrenergic activity has yet to be examined. The present study examined whether glucocorticoid administration enhances DLS-dependent memory and also whether this enhancement is contingent upon concurrent noradrenergic mechanisms. Experiment 1 employed two DLS-dependent memory tasks. The first task was a cued version of the Morris water maze in which rats were reinforced to approach a visibly cued escape platform. In the second task, rats were trained in a response-learning version of the water plus-maze in which they were released from varying start points and were reinforced to make a consistent egocentric turning response at the maze choice point to reach an invisible escape platform. To examine the influence of glucocorticoid administration on memory in these tasks, animals were given immediate post-training peripheral administration of corticosterone. In order to examine potential glucocorticoid-noradrenergic interactions in DLS-dependent memory, in experiment two different groups of rats were trained in the response version of the plus-maze and received post-training peripheral administration of either corticosterone, the b-adrenoreceptor antagonist propranolol, or concurrent infusions of corticosterone and propranolol.
EXPERIMENTAL PROCEDURES Subjects Subjects were 101 experimentally naı¨ ve Harlan Long– Evans rats (300–400 g). Rats were individually housed in a climate-controlled vivarium with a 12:12-h light–dark cycle (lights on at 7:00 AM) and behavioral procedures
were conducted during the light phase of this cycle. Rats received ad libitum access to food and water. Apparatus Animals were trained in a black circular water maze (1.83 m in diameter, 0.58 m in height) filled to a water level of 20 cm. Water temperature was maintained at 25 °C. A clear Plexiglas escape platform (11 cm 14 cm 19 cm) was located 1 cm below the water level and was moved to different spatial locations of the maze throughout training. In the cued version of the water maze task, a square white flag (4.5 cm per side) was attached to the escape platform. For the water plus-maze task, a clear Plexiglas plusmaze (43 cm in height, 25 cm in arm-width, and 60 cm in arm-length) was inserted into the water maze. Also, an additional piece of Plexiglas was used to block-off the arm opposite to the start arm for each trial (e.g. if the rat started in the S arm, entry to the N arm was blocked). This allowed for a T-maze configuration that could be adjusted between trials. No cue was attached to the platform for the water plus-maze task. The maze apparatus was identical to that used in our previous research (Goodman and Packard, 2014). Drug preparation Corticosterone hydrochloride (1.0 or 3.0 mg/kg) was dissolved in 8% ethanol saline. Corticosterone preparation and dosage were selected based on previous research indicating memory modulatory properties of corticosterone in rats (Quirarte et al., 2009). Peripheral injections of corticosterone were administered sub-cutaneously (s.c.). Propranolol hydrochloride (3 mg/kg) was dissolved in physiological saline and administered intra-peritoneally (i.p). This dose of propranolol was selected based on previous evidence indicating that this dose blocked corticosterone effects on memory (Roozendaal et al., 2006b). Behavioral procedures: experiment 1 Training in a cued version of the water maze was conducted over 1 day (4 trials) using a protocol similar to our previous research (Goodman and Packard, 2014). Previous evidence indicates that learning and memory in the cued water maze is critically dependent on DLS function (Packard et al., 1996; Packard and Teather, 1997; Lee et al., 2008; Goodman and Packard, 2014). For each trial, rats (N = 28) were placed into the water facing the maze wall at varying start points (N, S, E, and W). In addition, the visibly cued escape platform was rotated to a different quadrant of the maze (NE, SW, NW, and SE) for each trial. The platform’s distance (i.e. proximal or distal) and direction (i.e. right or left) relative to the rat’s starting position were counterbalanced across the training trials. Therefore, the swimming path was unique for each of the 4 trials. A trial ended once the animal mounted the escape platform. If an animal failed to find the escape platform within 60 s, the rat was manually guided to it. After mounting the platform,
3
J. Goodman et al. / Neuroscience 311 (2015) 1–8
the rat remained on the platform for 10 s. After each trial the animal was removed from the platform and placed in an opaque holding container adjacent to the maze for a 30-s intertrial interval (ITI). The latency to mount the escape platform was used as a measure of acquisition. After the four training trials in the cued water maze, rats were immediately injected s.c. with corticosterone (1.0 mg/kg, n = 8; 3.0 mg/kg, n = 10) or vehicle solution (8% ethanol-saline solution, n = 10). Twenty-four hours later, rats were given two drug-free probe trials conducted in a manner identical to initial training. Latency to mount the escape platform was used as a measure of memory. A separate group of rats (N = 22) was trained for 5 days (six trials/day) in a water plus-maze task that requires the use of response learning (Goodman and Packard, 2014; Wingard et al., 2015; for reviews, see Packard, 2009a; Goodman and Packard, in press). For each trial in this ‘‘response” version of the plus-maze task, rats were placed in the start arm of the plus-maze (N or S) facing the maze wall. The start arm sequence across the six trials was NSSNNS on odd training days (i.e. days 1, 3, and 5) and SNNSSN on even training days. When a rat started in the North arm, a transparent escape platform was in the West arm. When the animal started in the South arm, the escape platform was in the East arm. Therefore, regardless of the starting position, subjects were reinforced to make a consistent right bodyturn at the choice point of the T-maze in order to reach the escape platform. A trial ended once the animal mounted the platform. If an animal failed to find the escape platform within 60 s, the rat was manually guided to it. After mounting the platform, a rat remained in the maze for another 10 s. The rat was then removed from the platform and placed in an opaque holding container adjacent to the maze for a 30-s ITI. For each trial, if the rat made an initial full-body entry into the arm that contained the platform, the trial was scored as correct. If the rat made a full body entry into the arm that did not contain the platform, the trial was scored as incorrect. Immediately following training on days 1–3, each rat received a s.c. injection of corticosterone (1.0 mg/kg, n = 6; 3.0 mg/kg, n = 8) or vehicle (8% ethanol-saline solution, n = 8). Rats did not receive injections on days 4–5.
physiological saline and a s.c. injection of 8% ethanolsaline solution. Animals did not receive injections on training days 4–5.
RESULTS Experiment 1
Behavioral procedures: experiment 2
Post-training corticosterone injections enhance memory in the cued water maze. Results from the cued water maze task are depicted in Fig. 1. A two-way repeated measures ANOVA (Group Trial) computed on latency to find the escape platform on trials 1–4 (i.e. prior to post-training drug injections) revealed a main effect of Trial, (F(3,69) = 28.09, p < 0.05), but no main effect of Group (F(2,23) = 0.5, n.s.). In addition, there was no significant Group Trial interaction (F(2,23) = 0.03, n.s.). These results suggest that all groups acquired the task and that there were no differences between groups before drugs were administered. Therefore, any subsequent effects of drug may not be readily attributed to group differences in task acquisition occurring prior to drug injections. A two-way repeated measures ANOVA (Group Probe) was computed to determine the effect of post-training corticosterone administration on latency to find the platform on Probes 1 and 2 (i.e. 24 h after post-training drug administration). A two-way repeated measures ANOVA revealed a significant main effect of Group (F(2, 23) = 5.40, p < 0.05) and a significant main effect of Probe (F(1,23) = 4.32, p < 0.05). There was no significant Group Probe interaction (F(2,23) = .99, n.s.). A post-hoc Fisher’s Least Significant Difference (LSD) test revealed that rats given 3.0 mg/kg corticosterone displayed lower escape latencies during the probe trials (M = 8.81) relative to animals given vehicle solution (M = 14.85), p < .05. In addition, animals given 3.0 mg/kg corticosterone also displayed lower escape latencies than animals given 1.0 mg/kg corticosterone (M = 16.69), p < .05. There was no difference in escape latencies between animals given 1.0 mg/kg corticosterone and control animals given vehicle solution. Overall, the results indicate that post-training administration of corticosterone dosedependently enhanced DLS-dependent memory in a cued-platform water maze task.
Rats (N = 27) were trained in the response-learning version of the water plus-maze task, using a behavioral procedure identical to that described in experiment 1. Immediately following training on days 1–3, each rat received two injections. Animals in the CORT-VEH group (n = 7) received a s.c. injection of corticosterone (3.0 mg/kg) and an i.p. injection of physiological saline. Animals in the PROP-VEH group (n = 6) received an i.p. injection of propranolol (3.0 mg/kg) and a s.c. injection of 8% ethanol-saline solution (i.e. the vehicle solution used in corticosterone injections). Animals in the CORT-PROP group (n = 7) were given a s.c. injection of corticosterone (3.0 mg/kg) and an i.p. injection of propranolol (3.0 mg/kg). Finally, animals in the VEH-VEH group (n = 7) received an i.p. injection of
Post-training corticosterone injections enhance response learning in the plus-maze. Results from the water plus-maze task are depicted in Fig. 2. A two-way repeated measures ANCOVA (Group Day) was computed examining percentage of correct responses on days 2–5 (i.e. Day) and using percentage of correct responses on day 1 (i.e. before drugs were administered) as the covariate. There was a significant main effect of Group (F(2,18) = 3.97, p < .05) and Day (F(3,54) = 12.38, p < .001), but no Group Day interaction (F(6,54) = 1.60, n.s.). A post-hoc Fisher’s LSD test revealed that animals given post-training 3.0 mg/kg corticosterone displayed enhanced response learning in this task (M = 77.60) relative to animals given vehicle
4
J. Goodman et al. / Neuroscience 311 (2015) 1–8
Fig. 1. Effect of post-training s.c. injections of corticosterone on memory in the cued water maze task (mean latency in seconds ± standard error of the mean). All animals acquired the task without differences between groups on day 1, i.e. before drugs were administered (Left Panel). Rats given post-training s.c. injection of 3 mg/kg corticosterone displayed enhanced memory on two drug-free probe trials conducted 24 h after training (Right Panel). 1 mg/kg corticosterone did not have a significant effect on memory.
Fig. 2. Effect of post-training s.c. injections of corticosterone on memory for response learning in the water plus-maze task (mean percent correct ± standard error of the mean). Rats receiving post-training administration of 3 mg/kg corticosterone displayed a higher percentage of correct turning responses over training, relative to vehicle-treated control animals. 1 mg/kg corticosterone did not influence memory.
(M = 60.94), p < .05, or animals given a lower 1.0 mg/kg dose of corticosterone (M = 56.55), p < .05. In contrast, there was no difference in memory performance between animals given 1.0 mg/kg corticosterone and animals given vehicle. Taken together, these findings indicate that post-training administration of corticosterone dosedependently facilitated DLS-dependent response learning in the water plus-maze. Experiment 2 Corticosterone-induced enhancement of DLS-dependent response learning is blocked by concurrent administration of propranolol. Results from experiment 2 are depicted in Fig. 3. A three-way repeated measures ANCOVA (Corticosterone Propranolol Day) was computed examining percentage of correct responses on days 2–5 (i.e. Day) and using percentage of correct responses on day 1 (i.e. before drugs were administered) as the covariate. There was a significant main effect of Corticosterone (F(1,22) = 9.33, p < .01) and Propranolol (F(1,22) = 6.89, p < .05) and a significant Corticosterone Propranolol interaction (F(1,22) = 6.39, p < .05). There was a trend toward a significant effect of Day (F(3,66) = 1.81, p = .155),
but no Corticosterone Propranolol Day interaction (F(3,66) = .296, n.s.). A post-hoc Fisher’s LSD test revealed that animals in the CORT-VEH group displayed higher percentage of correct responses over the course of training (M = 77.38) relative to animals in the VEH-VEH group (M = 61.31), p < .01. Thus, similar to findings in experiment 1, corticosterone enhanced response learning in the plus-maze task. Fisher’s LSD test also indicated that animals in the PROP-VEH group displayed similar memory performance (M = 57.64) to animals in the VEH-VEH group (M = 61.31, n.s.), suggesting that 3.0 mg/kg propranolol did not by itself influence response learning in this task. Animals given concurrent administration of corticosterone and propranolol (i.e. the PROP-CORT group) also displayed similar memory performance (M = 61.91) to animals in the VEH-VEH group (M = 61.31, n.s.) and animals in the PROP-VEH group (M = 57.64, n.s.). In contrast, there was a significant difference in memory performance between animals in the CORT-VEH group and animals in the PROP-CORT group (M = 61.91, p < .01). Taken together, these results indicate that concurrent propranolol administration at a dose that alone did not influence memory blocked the corticosterone-induced enhancement of response learning.
J. Goodman et al. / Neuroscience 311 (2015) 1–8
5
Fig. 3. Effect of concurrent i.p. injections of propranolol on the corticosterone-induced enhancement of response learning in the water-plus maze task (mean percent correct ± standard error of the mean). Animals receiving injections of corticosterone (CORT-VEH) displayed enhanced memory, relative to animals receiving vehicle alone (VEH-VEH) or animals receiving concurrent injections of corticosterone and propranolol (CORTPROP). Propranolol by itself (PROP-VEH) did not influence memory. Findings indicate that propranolol at a dose that alone did not influence memory blocked the corticosterone-induced enhancement of memory.
DISCUSSION The present findings indicate that post-training peripheral administration of corticosterone facilitated memory in the DLS-dependent cued water maze and ‘‘response” plusmaze tasks. The use of post-training drug administration potentially prevented corticosterone from influencing online non-mnemonic processes (e.g. perception, motor behavior, etc) that operate during acquisition. Consistent with this suggestion, post-training administration of corticosterone following water maze training does not alter swim speed 24 h later (e.g. Sandi et al., 1997). It is reasonable to hypothesize that post-training corticosterone enhanced DLS-dependent memory in the present study by facilitating memory consolidation. Indeed, glucocorticoid administration 1 h after training (i.e. putatively outside the window of consolidation) does not influence dorsal striatum-dependent memory (Medina et al., 2007). Importantly, the present findings also indicate that the corticosterone-induced enhancement of response learning was blocked by concurrent administration of the b-adrenoreceptor antagonist propranolol. This provides novel evidence suggesting that glucocorticoid enhancement of DLS-dependent memory requires concurrent noradrenergic activity. The findings of experiment 2 are consistent with previous evidence indicating that glucocorticoid and noradrenergic mechanisms interact to influence learning and memory processes. Blockade of noradrenergic activity prevents glucocorticoid administration from enhancing consolidation of hippocampus- and amygdala-dependent cognitive/emotional memory (Quirarte et al., 1997; Roozendaal et al., 2006a,b). In addition, adrenoreceptor antagonists prevent corticosterone from impairing retrieval of cognitive/spatial memory (Roozendaal et al., 2004a,b,c; Schwabe et al., 2009). The present findings indicate that blockade of noradrenergic activity similarly prevents glucocorticoid stimulation from modulating DLS-dependent habit memory.
The effect of corticosterone administration on DLS-dependent memory resembles the memoryenhancing effects of emotional arousal. Administration of anxiogenic drugs or exposure to psychologically or ecologically valid stressors enhances DLS-dependent memory across a wide range of tasks (e.g. Leong and Packard, 2014; for reviews, see Packard and Goodman, 2012; Schwabe, 2013). The memory modulatory properties of emotional arousal on memory may be partially attributed to the release of adrenal stress hormones including glucocorticoids and adrenaline (McGaugh, 2004). Consistent with this suggestion, blockade of mineralocorticoid or b-adrenoreceptor activity is sufficient to prevent the stress-induced enhancement of habit memory (Schwabe et al., 2010a, 2011b). In learning situations where robust emotional arousal is not elicited, simultaneous administration of hydrocortisone and the a2-adrenoreceptor antagonist yohimbine enhances DLS-dependent habit memory, whereas the administration of either drug alone remains ineffective (Schwabe et al., 2010b, 2013). Thus, it is possible that both glucocorticoid and noradrenergic mechanisms need to be active for enhancement of habit memory to occur. Corticosterone administration alone might only enhance habit memory when the learning task elicits emotional arousal and when this emotional arousal leads to a sufficient rise in noradrenergic activity. In an object recognition task, corticosterone administration by itself may only influence recognition memory when the learning situation evokes emotional arousal and a consequent release in brain noradrenaline (Roozendaal et al., 2006b). In the present water maze tasks, mild swimming stress may have been sufficient to increase brain noradrenaline and thus allow corticosterone administration to be effective. However, propranolol administration may have attenuated the rise in noradrenergic activity produced by swimming stress, thus rendering corticosterone administration ineffective. Considering that all drugs were administered peripherally, drug treatments may have influenced learning and memory processes in the present study via
6
J. Goodman et al. / Neuroscience 311 (2015) 1–8
action on several brain regions. Corticosterone readily crosses the blood–brain barrier and binds to high-affinity mineralocorticoid and low-affinity glucocorticoid receptors in the rat brain (Reul and de Kloet, 1985; de Kloet et al., 1993). The dorsal striatum itself expresses glucocorticoid receptors (Ahima and Harlan, 1990, 1991; Morimoto et al., 1996), yet remains relatively devoid of mineralocorticoid receptors (Agarwal et al., 1993). Therefore, it is possible that in the present study peripheral corticosterone administration enhanced DLS-dependent habit memory directly by activating glucocorticoid receptors in the DLS. Consistent with this hypothesis, direct administration of corticosterone into the dorsal striatum enhances memory consolidation in inhibitory avoidance and cued water maze tasks (Medina et al., 2007; Quirarte et al., 2009; Sa´nchez-Resendis et al., 2012). However, it should be noted that in these previous studies corticosterone infusions were not selective to the medial or lateral aspects of the dorsal striatum, and therefore drug administrations may have influenced memory consolidation by increasing glucocorticoid activity in the dorsomedial striatum (DMS), DLS, or both. However, a subsequent study indicated that when corticosterone was selectively infused into the DMS, memory consolidation in the cued water maze remained unaffected (Lozano et al., 2013). Therefore, corticosterone might influence DLS-dependent memory in the cued water maze directly via glucocorticoid activity in the more lateral aspects of the dorsal striatum. In addition, given that the DLS also contains b-adrenoreceptors (Wanaka et al., 1989; Paschalis et al., 2009), it is possible that propranolol prevented the corticosterone-induced enhancement of habit memory in part by blocking b-adrenoreceptors in the DLS. Another important brain structure implicated in the emotional modulation of memory is the basolateral complex of the amygdala (BLA; McGaugh, 2004; Packard, 2009a,b; Roozendaal et al., 2009). Lesion or inactivation of the BLA blocks enhancement of DLSdependent habit memory produced by the administration of anxiogenic drugs or exposure to psychological or behavioral stressors (Kim et al., 2001; Packard and Gabriele, 2009; Leong and Packard, 2014). In addition, intra-BLA infusion of drugs that boost noradrenergic activity is sufficient to enhance DLS-dependent habit memory (Packard and Wingard, 2004; Elliott and Packard, 2008; Wingard and Packard, 2008), suggesting that the BLA noradrenergic system might have a critical role in the emotional enhancement of habit memory. The BLA has also been verified as an important locus for the effects of glucocorticoid and noradrenergic interactions on memory (Roozendaal et al., 2009). Stimulation of glucocorticoid receptors in the BLA enhances memory in an inhibitory avoidance task, and this effect may be attributed to glucocorticoids’ facilitation of BLA b-adrenoreceptors, which in turn stimulates the cAMPdependent protein kinase pathway (Roozendaal et al., 2002). Thus, the enhancing effect of BLA glucocorticoid receptor stimulation on memory is prevented following blockade of b-adrenoreceptors in the BLA (Quirarte et al., 1997). A similar mechanism centered on the BLA might underlie propranolol’s ability to block the
corticosterone-induced enhancement of DLS-dependent habit memory observed in the present study. Another brain region implicated in the stress/anxietyinduced enhancement of DLS-dependent memory is the hippocampus. In some learning situations, lesion or inactivation of the hippocampal formation is associated with enhanced DLS-dependent memory processes (Packard et al., 1989; McDonald and White, 1993; Schroeder et al., 2002). Likewise, stress/anxiety-induced impairment of hippocampal memory function may be associated with enhancement of DLS-dependent response learning in the water maze (Kim et al., 2001; Wingard and Packard, 2008; Packard and Gabriele, 2009). Given that systemic or intra-hippocampal glucocorticoids might similarly produce impairments in hippocampus-dependent memory retrieval (e.g. Luine et al., 1993; de Quervain et al., 1998; Roozendaal et al., 2003), corticosterone might have enhanced DLSdependent memory in the present study indirectly via disruption of the hippocampus-dependent memory system. Moreover, considering that propranolol administration can prevent glucocorticoids from impairing hippocampus-dependent memory retrieval (Roozendaal et al., 2004a; de Quervain et al., 2007), it is possible that propranolol’s ability to block the corticosterone-induced enhancement of habit memory might also have occurred indirectly via propranolol-mediated rescue of hippocampal function. However, in contrast to pre-retrieval administration, post-training glucocorticoid administration is associated with enhancement of hippocampus-dependent memory (Quirarte et al., 1997). Considering that the present study also utilized post-training drug administrations, it is reasonable to hypothesize that the effects of glucocorticoids on DLS-dependent memory may not be readily attributed to hippocampal dysfunction, but rather by glucocorticoid activity within the BLA and/or the DLS. Future studies employing direct intra-cerebral drug injections will be necessary to examine these hypotheses. The present finding that propranolol blocked the corticosterone-induced enhancement of DLS-dependent habit memory may provide novel clinical insights into the neurobiological mechanisms and potential treatments for some human psychopathologies. Multiple investigators have suggested that the formation and expression of habit-like symptoms might reflect dysfunction of the dorsal striatum-dependent memory system in a variety of neuropsychiatric disorders, including Tourette syndrome, obsessive-compulsive disorder, posttraumatic stress disorder, drug addiction and relapse, and others (White, 1996; Everitt and Robbins, 2005; Schwabe et al., 2011; Goodman et al., 2012, 2014; Berner and Marsh, 2014; Gillan and Robbins, 2014). Moreover, consistent with the emotional enhancement of habit memory, stress/anxiety may sometimes constitute a co-factor that contributes to the formation or exacerbation of habit-like symptoms in these disorders. Glucocorticoid release is a natural part of the stress response that, as suggested by the present findings, may enhance DLS-dependent habit memory. If this glucocorticoid-mediated process is part of the mechanism that allows stress to influence habit-like symptoms, then it
J. Goodman et al. / Neuroscience 311 (2015) 1–8
would be reasonable to hypothesize that the administration of propranolol might be useful in combating the stress-induced exacerbation of habitual behaviors in human psychopathology.
REFERENCES Agarwal MK, Mirshahi F, Mirshahi M, Rostene W (1993) Immunochemical detection of the mineralocorticoid receptor in rat brain. Neuroendocrinology 58(5):575–580. Ahima RS, Harlan RE (1990) Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39(3):579–604. Ahima RS, Harlan RE (1991) Differential corticosteroid regulation of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system: topography and implications. Endocrinology 129(1):226–236. Berner LA, Marsh R (2014) Frontostriatal circuits and the development of bulimia nervosa. Front Behav Neurosci. http:// dx.doi.org/10.3389/fnbeh.2014.00395. Conrad CD, Jackson JL, Wieczorek L, Baran SE, Harman JS, Wright RL, Korol DL (2004) Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacol Biochem Behav 78(3):569–579. de Kloet ER, Oitzl MS, Joe¨ls M (1993) Functional implications of brain corticosteroid receptor diversity. Cell Mol Neurobiol 13 (4):433–455. De Quervain DJF, Roozendaal B, McGaugh JL (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394(6695):787–790. de Quervain DJF, Aerni A, Roozendaal B (2007) Preventive effect of b-adrenoceptor blockade on glucocorticoid-induced memory retrieval deficits. Am J Psychiatr 164(6):967–969. Diamond DM, Fleshner M, Ingersoll N, Rose G (1996) Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav Neurosci 110(4):661–672. Elliott AE, Packard MG (2008) Intra-amygdala anxiogenic drug infusion prior to retrieval biases rats towards the use of habit memory. Neurobiol Learn Mem 90(4):616–623. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481–1489. Gillan CM, Robbins TW (2014) Goal-directed learning and obsessivecompulsive disorder. Philos Trans R Soc Lond B Biol Sci. http:// dx.doi.org/10.1098/rstb.2013.0475. Goodman J, Packard MG (2014) Peripheral and intra-dorsolateral striatum injections of the cannabinoid receptor agonist WIN 55,212–2 impair consolidation of stimulus–response memory. Neuroscience 274:128–137. Goodman J, Packard MG (in press) Memory systems of the basal ganglia. In: Handbook of basal ganglia structure and function second edition (Steiner H, Tseng KY, eds), Academic Press/ Elsevier. Goodman J, Leong K-C, Packard MG (2012) Emotional modulation of multiple memory systems: implications for the neurobiology of post-traumatic stress disorder. Rev Neurosci 23:627–643. Goodman J, Marsh R, Peterson BS, Packard MG (2014) Annual research review: the neurobehavioral development of multiple memory systems—implications for childhood and adolescent psychiatric disorders. J Child Psychol Psychiatry 55:582–610. Guenzel FM, Wolf OT, Schwabe L (2014) Glucocorticoids boost stimulus-response memory formation in humans. Psychoneuroendocrinology 45:21–30. Hawley WR, Grissom EM, Dohanich GP (2011) The relationships between trait anxiety, place recognition memory, and learning strategy. Behav Brain Res 216(2):525–530. Kim JJ, Lee HJ, Han JS, Packard MG (2001) Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J Neurosci 21(14):5222–5228.
7
Lee AS, Duman RS, Pittenger C (2008) A double dissociation revealing bidirectional competition between striatum and hippocampus during learning. Proc Natl Acad Sci USA 105:17163–17168. Leong K-C, Packard MG (2014) Exposure to predator odor influences the relative use of multiple memory systems: role of basolateral amygdala. Neurobiol Learn Mem 109:56–61. Leong K-C, Goodman J, Packard MG (2012) Buspirone blocks the enhancing effect of the anxiogenic drug RS 79948–197 on consolidation of habit memory. Behav Brain Res 234(2):299–302. Leong K-C, Goodman J, Packard MG (2015) Post-training reexposure to fear conditioned stimuli enhances memory consolidation and biases rats toward the use of dorsolateral striatum-dependent response learning. Behav Brain Res 291:195–200. Lozano YR, Serafı´ n N, Prado-Alcala´ RA, Roozendaal B, Quirarte GL (2013) Glucocorticoids in the dorsomedial striatum modulate the consolidation of spatial but not procedural memory. Neurobiol Learn Mem 101:55–64. Luine VN, Spencer RL, McEwen BS (1993) Effects of chronic corticosterone ingestion on spatial memory performance and hippocampal serotonergic function. Brain Res 616(1):65–70. Luine V, Villegas M, Martinez C, McEwen BS (1994) Repeated stress causes reversible impairments of spatial memory performance. Brain Res 639(1):167–170. Maroun M, Akirav I (2008) Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology 33(2):394–405. McDonald RJ, White NM (1993) A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav Neurosci 107(1):3–22. McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Ann Rev Neurosci 27:1–28. Medina AC, Charles JR, Espinoza-Gonza´lez V, Sa´nchez-Resendis O, Prado-Alcala´ RA, Roozendaal B, Quirarte GL (2007) Glucocorticoid administration into the dorsal stratium facilitates memory consolidation of inhibitory avoidance training but not of the context or footshock components. Learn Mem 14 (10):673–677. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M (1996) Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci Res 26(3):235–269. Packard MG (2009a) Exhumed from thought: basal ganglia and response learning in the plus-maze. Behav Brain Res 199 (1):24–31. Packard MG (2009b) Anxiety, cognition, and habit: a multiple memory systems perspective. Brain Res 1293:121–128. Packard MG, Gabriele A (2009) Peripheral anxiogenic drug injections differentially affect cognitive and habit memory: role of basolateral amygdala. Neuroscience 164(2):457–462. Packard MG, Goodman J (2012) Emotional arousal and multiple memory systems in the mammalian brain. Front Behav Neurosci 6. Packard MG, Goodman J (2013) Factors that influence the relative use of multiple memory systems. Hippocampus 23 (11):1044–1052. Packard MG, Teather LA (1997) Double dissociation of hippocampal and dorsal-striatal memory systems by posttraining intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav Neurosci 111(3):543. Packard MG, Wingard JC (2004) Amygdala and ‘‘emotional” modulation of the relative use of multiple memory systems. Neurobiol Learn Mem 82(3):243–252. Packard MG, Hirsh R, White NM (1989) Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems. J Neurosci 9(5):1465–1472. Packard MG, Teather LA, Bazan NG (1996) Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory. Neurobiol Learn Mem 66(2):176–182.
8
J. Goodman et al. / Neuroscience 311 (2015) 1–8
Paschalis A, Churchill L, Marina N, Kasymov V, Gourine A, Ackland G (2009) b1-Adrenoceptor distribution in the rat brain: an immunohistochemical study. Neurosci Lett 458(2):84–88. Quirarte GL, Roozendaal B, McGaugh JL (1997) Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci 94 (25):14048–14053. Quirarte GL, de la Teja ISL, Casillas M, Serafı´ n N, Prado-Alcala´ RA, Roozendaal B (2009) Corticosterone infused into the dorsal striatum selectively enhances memory consolidation of cued water-maze training. Learn Mem 16(10):586–589. Reul JMHM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117(6):2505–2511. Roozendaal B, Quirarte GL, McGaugh JL (2002) Glucocorticoids interact with the basolateral amygdala b-adrenoceptor–cAMP/ cAMP/PKA system in influencing memory consolidation. Eur J Neurosci 15(3):553–560. Roozendaal B, Griffith QK, Buranday J, de Quervain DJF, McGaugh JL (2003) The hippocampus mediates glucocorticoid-induced impairment of spatial memory retrieval: dependence on the basolateral amygdala. Proc Natl Acad Sci 100(3):1328–1333. Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ-F, McGaugh JL (2004a) Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24(37):8161–8169. Roozendaal B, McReynolds JR, McGaugh JL (2004b) The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci 24(6):1385–1392. Roozendaal B, de Quervain DJ-F, Schelling G, McGaugh JL (2004c) A systemically administered b-adrenoceptor antagonist blocks corticosterone-induced impairment of contextual memory retrieval in rats. Neurobiol Learn Mem 81(2):150–154. Roozendaal B, Hui GK, Hui IR, Berlau DJ, McGaugh JL, Weinberger NM (2006a) Basolateral amygdala noradrenergic activity mediates corticosterone-induced enhancement of auditory fear conditioning. Neurobiol Learn Mem 86(3):249–255. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL (2006b) Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci 103(17):6741–6746. Roozendaal B, McEwen BS, Chattarji S (2009) Stress, memory and the amygdala. Nat Rev Neurosci 10(6):423–433. Sa´nchez-Resendis O, Medina AC, Serafı´ n N, Prado-Alcala´ RA, Roozendaal B, Quirarte GL (2012) Glucocorticoid-cholinergic interactions in the dorsal striatum in memory consolidation of inhibitory avoidance training. Front Behav Neurosci 6:33. http:// dx.doi.org/10.3389/fnbeh.2012.00033. Sandi C, Loscertales M, Guaza C (1997) Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur J Neurosci 9(4):637–642.
Schroeder JP, Wingard JC, Packard MG (2002) Post-training reversible inactivation of hippocampus reveals interference between memory systems. Hippocampus 12(2):280–284. Schwabe L (2013) Stress and the engagement of multiple memory systems: integration of animal and human studies. Hippocampus 23:1035–1043. Schwabe L, Wolf OT (2009) Stress prompts habit behavior in humans. J Neurosci 29:7191–7198. Schwabe L, Wolf OT (2010) Socially evaluated cold pressor stress after instrumental learning favors habits over goal-directed action. Psychoneuroendocrinology 35:977–986. Schwabe L, Oitzl MS, Philippsen C, Richter S, Bohringer A, Wippich W, Schachinger H (2007) Stress modulates the use of spatial versus stimulus-response learning strategies in humans. Learn Mem 14:109–116. Schwabe L, Dalm S, Scha¨chinger H, Oitzl MS (2008) Chronic stress modulates the use of spatial and stimulus-response learning strategies in mice and man. Neurobiol Learn Mem 90:495–503. Schwabe L, Ro¨mer S, Richter S, Dockendorf S, Bilak B, Scha¨chinger H (2009) Stress effects on declarative memory retrieval are blocked by a b-adrenoceptor antagonist in humans. Psychoneuroendocrinology 34(3):446–454. Schwabe L, Scha¨chinger H, de Kloet ER, Oitzl MS (2010a) Corticosteroids operate as a switch between memory systems. J Cogn Neurosci 22(7):1362–1372. Schwabe L, Tegenthoff M, Ho¨ffken O, Wolf OT (2010b) Concurrent glucocorticoid and noradrenergic activity shifts instrumental behavior from goal-directed to habitual control. J Neurosci 30:8190–8196. Schwabe L, Dickinson A, Wolf OT (2011a) Stress, habits, and drug addiction: a psychoneuroendocrinological perspective. Exp Clin Psychopharmacol 19:53–63. Schwabe L, Ho¨ffken O, Tegenthoff M, Wolf OT (2011b) Preventing the stress-induced shift from goal-directed to habit action with a badrenergic antagonist. J Neurosci 31(47):17317–17325. Schwabe L, Tegenthoff M, Ho¨ffken O, Wolf OT (2013) Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain. Biol Psychiatry 74(11):801–808. Wanaka A, Kiyama H, Murakami T, Matsumoto M, Kamada T, Malbon CC, Tohyama M (1989) Immunocytochemical localization of b-adrenergic receptors in the rat brain. Brain Res 485 (1):125–140. White NM (1996) Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91:921–950. Wingard JC, Packard MG (2008) The amygdala and emotional modulation of competition between cognitive and habit memory. Behav Brain Res 193(1):126–131. Wingard JC, Goodman J, Leong KC, Packard MG (2015) Differential effects of massed and spaced training on place and response learning: a memory systems perspective. Behav Process 118:85–89.
(Accepted 8 October 2015) (Available online xxxx)